Verastem Oncology
 | This article needs additional citations for verification. (October 2023) |
Verastem Oncology is a biopharmaceutical company focused on developing and commercializing medicines to improve the lives of patients with cancer. The company is headquartered in Needham, Massachusetts, United States.
History[edit | edit source]
Verastem Oncology was founded in 2010 by a group of scientists and entrepreneurs, including Robert Weinberg, a prominent cancer researcher. The company was established with the goal of developing therapies targeting cancer stem cells, which are believed to be responsible for tumor growth and recurrence.
In 2012, Verastem went public and was listed on the NASDAQ stock exchange under the ticker symbol VSTM. Over the years, the company has focused on developing treatments for various types of cancer, including leukemia, lymphoma, and solid tumors.
Research and Development[edit | edit source]
Verastem Oncology's research is centered on targeting cancer stem cells and the tumor microenvironment. The company has developed a pipeline of drug candidates that aim to disrupt the signaling pathways critical for cancer cell survival and proliferation.
One of the company's lead products is duvelisib, an oral dual inhibitor of PI3K-delta and PI3K-gamma, which has been approved for the treatment of certain types of blood cancers. Verastem is also exploring the potential of other compounds in its pipeline for the treatment of solid tumors.
Collaborations and Partnerships[edit | edit source]
Verastem Oncology has entered into several strategic collaborations and partnerships to advance its research and development efforts. These partnerships have included collaborations with academic institutions, research organizations, and other pharmaceutical companies to enhance the development of its drug candidates.
Market and Financials[edit | edit source]
As a publicly traded company, Verastem Oncology reports its financial performance on a quarterly basis. The company generates revenue primarily through the sale of its approved products and through licensing agreements with other companies.
Related pages[edit | edit source]
References[edit | edit source]
Official company logo
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
